McNeeley P - Search Results

1

Identification of a peptide that protects the human acetylcholine receptor against antigenic modulation.

Luo GX, Victor K, Chong K, McNeeley P, Ramirez D, Preclaro J, Linnik MD, Campbell MA. Luo GX, et al. Among authors: mcneeley p. J Immunol Methods. 2001 May 1;251(1-2):177-86. doi: 10.1016/s0022-1759(01)00296-4. J Immunol Methods. 2001. PMID: 11292492

2

Antibody affinities and relative titers in polyclonal populations: surface plasmon resonance analysis of anti-DNA antibodies.

Sem DS, McNeeley PA, Linnik MD. Sem DS, et al. Among authors: mcneeley pa. Arch Biochem Biophys. 1999 Dec 1;372(1):62-8. doi: 10.1006/abbi.1999.1469. Arch Biochem Biophys. 1999. PMID: 10562417

3

Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.

McNeeley PA, Dlott JS, Furie RA, Jack RM, Ortel TL, Triplett DA, Victoria EJ, Linnik MD. McNeeley PA, et al. Thromb Haemost. 2001 Aug;86(2):590-5. Thromb Haemost. 2001. PMID: 11522008

4

Synthesis of LJP 993, a multivalent conjugate of the N-terminal domain of beta2GPI and suppression of an anti-beta2GPI immune response.

Jones DS, Cockerill KA, Gamino CA, Hammaker JR, Hayag MS, Iverson GM, Linnik MD, McNeeley PA, Tedder ME, Ton-Nu HT, Victoria EJ. Jones DS, et al. Among authors: mcneeley pa. Bioconjug Chem. 2001 Nov-Dec;12(6):1012-20. doi: 10.1021/bc015512x. Bioconjug Chem. 2001. PMID: 11716694

5

Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients.

McNeeley PA, Iverson GM, Furie RA, Cash JM, Cronin ME, Katz RS, Weisman MH, Aranow C, Linnik MD. McNeeley PA, et al. Lupus. 2001;10(8):526-32. doi: 10.1191/096120301701549642. Lupus. 2001. PMID: 11530993 Clinical Trial.

6

Application of fluorescence polarization to the steady-state enzyme kinetic analysis of calpain II.

Sem DS, McNeeley PA. Sem DS, et al. Among authors: mcneeley pa. FEBS Lett. 1999 Jan 22;443(1):17-9. doi: 10.1016/s0014-5793(98)01655-x. FEBS Lett. 1999. PMID: 9928944 Free article.

7

Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic leukemia.

Nerenberg M, Kariv I, McNeeley P, Marchand P, Sur S, Diver J, Riccitelli S, Nieva J, Saven A. Nerenberg M, et al. Among authors: mcneeley p. Leuk Lymphoma. 2006 Oct;47(10):2194-202. doi: 10.1080/10428190600799532. Leuk Lymphoma. 2006. PMID: 17071495

8

RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist.

Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, Dawson MW, Flippin LA, Eglen RM. Bonhaus DW, et al. Among authors: mcneeley pm. Neuropharmacology. 1997 Apr-May;36(4-5):621-9. doi: 10.1016/s0028-3908(97)00049-x. Neuropharmacology. 1997. PMID: 9225287

9

Evaluation of human astrocytoma and glioblastoma cell lines for nerve growth factor release.

Emmett CJ, McNeeley PA, Johnson RM. Emmett CJ, et al. Among authors: mcneeley pa. Neurochem Int. 1997 Apr-May;30(4-5):465-74. doi: 10.1016/s0197-0186(96)00083-6. Neurochem Int. 1997. PMID: 9106262

10

Interleukin-1 beta induces nerve growth factor release and gene expression in human glioblastoma cells.

McNeeley PA, Baecker PA, Jones NL, Emmett CJ, Eglen RM, Wong EH, Johnson RM. McNeeley PA, et al. Proc West Pharmacol Soc. 1995;38:63-6. Proc West Pharmacol Soc. 1995. PMID: 7480024 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters